Results of JSC Avexima Participation in the CPhI China 2019 Pharmaceutical Exhibition

Avexima participated in the Chinese international pharmaceutical industry exhibition CPhI 2019, which was held on June 18-20, 2019, in Shanghai.

This is the largest industry event in Asia, bringing together over 3,000 pharmaceutical manufacturers, suppliers and distributors from 120 countries. Participation in the exhibition was aimed at strengthening and expanding the company's position in the pharmaceutical manufacturers' segment, as well as increasing its recognition among potential partners.

The booth of JSC Avexima presented information on the capabilities for organizing contract manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs), as well as on its own original drugs with export potential.

As part of the business program, representatives of the Strategic Marketing and Foreign Economic Activity departments of JSC Avexima held working meetings with licensors, current and new counterparties. These meetings resulted in agreements on technology transfer and joint production of medicines, as well as on the export of JSC Avexima products to non-CIS countries.

Several agreements were signed on further cooperation regarding the supply of active pharmaceutical ingredients and finished dosage forms, with the aim of promoting them under the Avexima brand.